Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818490 · ClinicalTrials.gov registry record · NA
Aromatherapy for Anxiety Among Children With Autism Spectrum Disorder
A NA study, sponsored by Nutraceuticals Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03818490 is a NA study that has completed, run by Nutraceuticals Research Institute. The registered enrollment target is 28 participants.
The verdict
NCT03818490, a NA study, has completed, sponsored by Nutraceuticals Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study evaluated the use of bergamot aromatherapy in the treatment of anxiety in a medical office setting among children who are diagnosed with an autism spectrum disorder. H
Interventions
- OTHER Bergamot Aromatherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-06-24 |
| Est. Completion | 2018-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03818490
The ClinicalTrials.gov registry entry for NCT03818490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nutraceuticals Research Institute, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bergamot Aromatherapy is the first listed.
NCT03818490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03818490 about?
NCT03818490 is a clinical study titled "Aromatherapy for Anxiety Among Children With Autism Spectrum Disorder". This study evaluated the use of bergamot aromatherapy in the treatment of anxiety in a medical office setting among children who are diagnosed with an autism spectrum disorder. H
What is the current status of trial NCT03818490?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2016-06-24. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT03818490?
The interventions under investigation include: Bergamot Aromatherapy (OTHER).
Who is sponsoring clinical trial NCT03818490?
This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.